Centivax | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Centivax is a biotechnology company based in South San Francisco, California, dedicated to developing broad-spectrum vaccines and therapies. Founded during the COVID-19 pandemic, the company utilizes a proprietary computational immune-engineering platform to create vaccines that offer universal protection against various classes of pathogens. Their mission is to protect against a wide range of infectious diseases, including influenza, HIV, COVID-19, and more.

Their lead candidate is a universal influenza vaccine currently in pre-clinical development, with testing conducted in animal models. The pipeline also includes work on universal vaccines for diseases such as HIV, malaria, and tuberculosis, as well as exploratory applications for livestock and military settings. Centivax collaborates with global health organizations and government agencies, such as the Bill & Melinda Gates Foundation and the National Institutes of Health, to address major health challenges and strengthen biodefense initiatives.